“At the early stage, you’ve got to be hands-on, get involved with everything and everyone, and really understand your own limitations,” he added. For emerging biotechs, this combination of strategic ...

Over the past decade, the economics of drug development have become increasingly unforgiving. Global pharmaceutical R&D spending now exceeds $300 billion annually, yet bringing a new therapy to market ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

The complex and redundant biology underlying fibrosis is widely believed to contribute to the limited effectiveness of single-target approaches. “Fibrosis is a biologically complex, organ-specific ...

Metropolitan Community College is launching a new biotechnology program designed to prepare students for careers in one of ...

The biotechnology program launching this fall at the Omaha area's Metropolitan Community College was developed in partnership with local employers and features a state-of-the-art lab.

As Congress mulls whether to follow President Donald Trump’s orders for a most-favored-nation drug-pricing policy, biotech firm executives are starting to speak out against the measure.

Biotech firm launches initiative linking producers and retailers to grow fruits and vegetables meeting quality, safety, ...

The Company’s presence at ATTD follows compelling clinical performance data from its latest CGM technology developments, which formed the basis for Trinity Biotech’s decision to advance the program ...